Association of a microsatellite in FASL to type II diabetes and of the FAS-670G> A genotype to insulin resistance

Genes and Immunity

Volumn 7, Issue 4, 2006, Pages 316-321

  Nolsoe R L ^a   Hamid, Y H ^a   Pociot, F ^a,c   Paulsen, S ^a   Andersen, K M ^a   Borch Johnsen, K ^a   Drivsholm, T ^b   Hansen, T ^a   Pedersen, O ^a,d   Mandrup Poulsen, T ^a,e  

^a STENO DIABETES CENTER   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d AARHUS UNIVERSITY   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

FAS; FASL; Functional variants; Genetics; Insulin resistance; Type II diabetes

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLUCOSE; INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3' UNTRANSLATED REGIONS; ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; DENMARK; DIABETES MELLITUS, TYPE 2; FAS LIGAND PROTEIN; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MEMBRANE GLYCOPROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); QUANTITATIVE TRAIT, HERITABLE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 33745054115     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364300     Document Type: Article

References (34)

1. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Syn Pathol Res 1985; 4 (2): 110-125.
2. Rich SS. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 1990; 39 (11): 1315-1319.
3. Ghosh S, Hauser ER, Magnuson VL, Valle T, Ally DS, Karanjawala ZE et al. A large sample of Finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter. J Clin Invest 1998; 102 (4): 704-709.
4. Poulsen P, Ohm Kyvik K, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study. Diabetologia 1999; 42 (2): 139-145.
5. Andersen G, Hansen T, Pedersen O. Genetics of common forms of glycaemia with pathological impact on vascular biology: Are we on the right tract? Curr Mol Med 2005; 5 (3): 261-274.
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52 (1): 102-110.
7. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002; 45 (1): 85-96.
8. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52 (3): 812-817.
9. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A et al. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001; 50 (8): 1683-1690.
10. Loweth AC, Williams GT, James RFL, Scarpello JHB, Morgan NG. Human islets of Langerhans express fas ligand and undergo apoptosis in response to interleukin-1β and fas ligation. Diabetes 1998; 47 (5): 727-732.
11. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M et al. A genomewide scan for loci predisposing to type 2 diabetes in a UK population (The diabetes UK Warren 2 repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001; 69 (3): 553-569.
12. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD et al. The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000; 67 (5): 1174-1185.
13. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
14. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 326 (Part 1): 1-16.
15. Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J et al. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. Proc Natl Acad Sci USA 2002; 99 (12): 8236-8241.
16. Nolsoe RL, Kristiansen OP, Sangthongpitag K, Larsen ZM, Johannesen J, Karlsen AE et al. Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. Diabetologia 2000; 43 (6): 800-808.
17. Nolsoe RL, Kristiansen OP, Larsen ZM, Johannesen J, Pociot F, Mandrup-Poulsen T. Complete mutation scan of the human Fas ligand gene: linkage studies in type I diabetes mellitus families. Diabetologia 2002; 45 (1): 134-139.
18. Nolsoe RL, Kelly JA, Pociot F, Moser KL, Kristiansen OP, Mandrup-Poulsen T et al. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 2005; 6 (8): 699-706.
19. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110 (6): 851-860.
20. Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L et al. FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med 2005; 202 (7): 967-974.
21. Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: A candidate background gene in African American systemic lupus erythematosus patients. J Immunol 2003; 170 (1): 132-138.
22. Welsh N, Cnop M, Kharroubi I, Bugliani M, Lupi R, Marchetti P et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005; 54 (11): 3238-3244.
23. Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14 (1): 53-66.
24. Kaneto H. The JNK pathways as a therapeutic target for diabetes. Expert Opin Ther Targets 2005; 9 (3): 581-592.
25. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420 (6913): 333-336.
26. Lee YH, Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 2003; 278 (5): 2896-2902.
27. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 2004; 10 (10): 1128-1132.
28. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998; 63 (4): 1130-1138.
29. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 1999; 48 (5): 1175-1182.
30. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67 (6): 1470-1480.
31. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabetic Med 2001; 18 (2): 126-132.
32. WHO Study Group. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization: Geneva, 1999 Ref Type: Pamphlet.
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 (7): 412-419.
34. Kosaka K, Hagura R, Kuzuya T, Kuzuya N. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 1974; 10 (6): 775-782.